Back to search

Spain· ES:1252011002

CENRIFKI 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

A medicinal product containing tolebrutinib, registered in Spain by Sanofi Winthrop Industrie.

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedCENRIFKI 60 MG COMPRIMIDOS RECUBIERTO…ATC—REGISTER NO.ES:1252011002PACKS LISTED0CHECKEDAugust 10, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
tolebrutinib
Manufacturer
Sanofi Winthrop Industrie
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
August 10, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tolebrutinib in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tolebrutinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Cenrifki
  • Liechtenstein · Cenrifki
  • Norway · Cenrifki

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2a049163-05f5-4d4d-aaf2-1a032bf83d36
GET /v1/drugs/2a049163-05f5-4d4d-aaf2-1a032bf83d36?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":1785998043000}",
  "nregistro": "1252011002",
  "substance": "tolebrutinib"
}

See everything about tolebrutinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.